Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 202

1.

Risk of Subsequent Sepsis within 90 Days of a Previous Hospital Stay by Type of Antibiotic Exposure.

Baggs J, Jernigan JA, Halpin AL, Epstein LH, Hatfield KM, McDonald LC.

Clin Infect Dis. 2017 Nov 9. doi: 10.1093/cid/cix947. [Epub ahead of print]

PMID:
29136126
2.

Duration of Antibiotic Use among Adults with Uncomplicated Community-Acquired Pneumonia Requiring Hospitalization in the United States.

Yi SH, Hatfield KM, Baggs J, Hicks LA, Srinivasan A, Reddy S, Jernigan JA.

Clin Infect Dis. 2017 Nov 6. doi: 10.1093/cid/cix986. [Epub ahead of print]

PMID:
29126268
3.

Incidence and Trends of Sepsis in US Hospitals Using Clinical vs Claims Data, 2009-2014.

Rhee C, Dantes R, Epstein L, Murphy DJ, Seymour CW, Iwashyna TJ, Kadri SS, Angus DC, Danner RL, Fiore AE, Jernigan JA, Martin GS, Septimus E, Warren DK, Karcz A, Chan C, Menchaca JT, Wang R, Gruber S, Klompas M; CDC Prevention Epicenter Program.

JAMA. 2017 Oct 3;318(13):1241-1249. doi: 10.1001/jama.2017.13836.

PMID:
28903154
4.

Attributable Mortality of Healthcare-Associated Infections Due to Multidrug-Resistant Gram-Negative Bacteria and Methicillin-Resistant Staphylococcus Aureus.

Nelson RE, Slayton RB, Stevens VW, Jones MM, Khader K, Rubin MA, Jernigan JA, Samore MH.

Infect Control Hosp Epidemiol. 2017 Jul;38(7):848-856. doi: 10.1017/ice.2017.83. Epub 2017 Jun 1.

PMID:
28566096
5.

The Potential for Interventions in a Long-term Acute Care Hospital to Reduce Transmission of Carbapenem-Resistant Enterobacteriaceae in Affiliated Healthcare Facilities.

Toth DJA, Khader K, Slayton RB, Kallen AJ, Gundlapalli AV, O'Hagan JJ, Fiore AE, Rubin MA, Jernigan JA, Samore MH.

Clin Infect Dis. 2017 Aug 15;65(4):581-587. doi: 10.1093/cid/cix370.

PMID:
28472233
6.

Risk Factors for Middle East Respiratory Syndrome Coronavirus Infection among Healthcare Personnel.

Alraddadi BM, Al-Salmi HS, Jacobs-Slifka K, Slayton RB, Estivariz CF, Geller AI, Al-Turkistani HH, Al-Rehily SS, Alserehi HA, Wali GY, Alshukairi AN, Azhar EI, Haynes L, Swerdlow DL, Jernigan JA, Madani TA.

Emerg Infect Dis. 2016 Nov;22(11):1915-1920. doi: 10.3201/eid2211.160920.

7.

Phosphate treatment by onsite wastewater systems in nutrient-sensitive watersheds of North Carolina's Piedmont.

Humphrey C, Serozi B, Iverson G, Jernigan J, Pradhan S, O'Driscoll M, Bean E.

Water Sci Technol. 2016 Oct;74(7):1527-1538.

PMID:
27763333
8.

Estimating National Trends in Inpatient Antibiotic Use Among US Hospitals From 2006 to 2012.

Baggs J, Fridkin SK, Pollack LA, Srinivasan A, Jernigan JA.

JAMA Intern Med. 2016 Nov 1;176(11):1639-1648. doi: 10.1001/jamainternmed.2016.5651.

PMID:
27653796
9.

Impact of Delays between Clinical and Laboratory Standards Institute and Food and Drug Administration Revisions of Interpretive Criteria for Carbapenem-Resistant Enterobacteriaceae.

Bartsch SM, Huang SS, Wong KF, Slayton RB, McKinnell JA, Sahm DF, Kazmierczak K, Mueller LE, Jernigan JA, Lee BY.

J Clin Microbiol. 2016 Nov;54(11):2757-2762. Epub 2016 Aug 31.

10.

Vital Signs: Epidemiology of Sepsis: Prevalence of Health Care Factors and Opportunities for Prevention.

Novosad SA, Sapiano MR, Grigg C, Lake J, Robyn M, Dumyati G, Felsen C, Blog D, Dufort E, Zansky S, Wiedeman K, Avery L, Dantes RB, Jernigan JA, Magill SS, Fiore A, Epstein L.

MMWR Morb Mortal Wkly Rep. 2016 Aug 26;65(33):864-9. doi: 10.15585/mmwr.mm6533e1.

11.

Chlorhexidine and Mupirocin Susceptibility of Methicillin-Resistant Staphylococcus aureus Isolates in the REDUCE-MRSA Trial.

Hayden MK, Lolans K, Haffenreffer K, Avery TR, Kleinman K, Li H, Kaganov RE, Lankiewicz J, Moody J, Septimus E, Weinstein RA, Hickok J, Jernigan J, Perlin JB, Platt R, Huang SS.

J Clin Microbiol. 2016 Nov;54(11):2735-2742. Epub 2016 Aug 24.

12.

Factors Associated With Inter-Hospital Variability of Inpatient Antibiotic Use in a Cohort of US Hospitals.

Baggs J, Fridkin S, Pollack L, Srinivasan A, Jernigan J.

Open Forum Infect Dis. 2015 Dec 9;2(Suppl 1):685. doi: 10.1093/ofid/ofv131.61. eCollection 2015 Dec. No abstract available.

13.

Vital Signs: Preventing Antibiotic-Resistant Infections in Hospitals - United States, 2014.

Weiner LM, Fridkin SK, Aponte-Torres Z, Avery L, Coffin N, Dudeck MA, Edwards JR, Jernigan JA, Konnor R, Soe MM, Peterson K, Clifford McDonald L.

Am J Transplant. 2016 Jul;16(7):2224-30. doi: 10.1111/ajt.13893.

14.

Outbreak of Middle East Respiratory Syndrome at Tertiary Care Hospital, Jeddah, Saudi Arabia, 2014.

Hastings DL, Tokars JI, Abdel Aziz IZ, Alkhaldi KZ, Bensadek AT, Alraddadi BM, Jokhdar H, Jernigan JA, Garout MA, Tomczyk SM, Oboho IK, Geller AI, Arinaminpathy N, Swerdlow DL, Madani TA.

Emerg Infect Dis. 2016 May;22(5):794-801. doi: 10.3201/eid2205.151797.

15.

Vital Signs: Preventing Antibiotic-Resistant Infections in Hospitals - United States, 2014.

Weiner LM, Fridkin SK, Aponte-Torres Z, Avery L, Coffin N, Dudeck MA, Edwards JR, Jernigan JA, Konnor R, Soe MM, Peterson K, McDonald LC.

MMWR Morb Mortal Wkly Rep. 2016 Mar 11;65(9):235-41. doi: 10.15585/mmwr.mm6509e1.

16.

Evaluation of the Physical Activity and Public Health Course for Practitioners.

Evenson KR, Brown DR, Pearce E, Camplain R, Jernigan J, Epping J, Shepard DM, Dorn JM.

Res Q Exerc Sport. 2016 Jun;87(2):207-13. doi: 10.1080/02701367.2016.1146942. Epub 2016 Mar 9.

17.

Sustained Infection Reduction in Outpatient Hemodialysis Centers Participating in a Collaborative Bloodstream Infection Prevention Effort.

Yi SH, Kallen AJ, Hess S, Bren VR, Lincoln ME, Downham G, Kelley K, Booth SL, Weirich H, Shugart A, Lines C, Melville A, Jernigan JA, Kleinbaum DG, Patel PR.

Infect Control Hosp Epidemiol. 2016 Jul;37(7):863-6. doi: 10.1017/ice.2016.22. Epub 2016 Feb 12.

PMID:
26868605
18.

The Potential Trajectory of Carbapenem-Resistant Enterobacteriaceae, an Emerging Threat to Health-Care Facilities, and the Impact of the Centers for Disease Control and Prevention Toolkit.

Lee BY, Bartsch SM, Wong KF, McKinnell JA, Slayton RB, Miller LG, Cao C, Kim DS, Kallen AJ, Jernigan JA, Huang SS.

Am J Epidemiol. 2016 Mar 1;183(5):471-9. doi: 10.1093/aje/kwv299. Epub 2016 Feb 8.

19.

Prevalence of probiotic use among inpatients: A descriptive study of 145 U.S. hospitals.

Yi SH, Jernigan JA, McDonald LC.

Am J Infect Control. 2016 May 1;44(5):548-53. doi: 10.1016/j.ajic.2015.12.001. Epub 2016 Jan 25.

PMID:
26822808
20.

Effect of body surface decolonisation on bacteriuria and candiduria in intensive care units: an analysis of a cluster-randomised trial.

Huang SS, Septimus E, Hayden MK, Kleinman K, Sturtevant J, Avery TR, Moody J, Hickok J, Lankiewicz J, Gombosev A, Kaganov RE, Haffenreffer K, Jernigan JA, Perlin JB, Platt R, Weinstein RA; Agency for Healthcare Research and Quality (AHRQ) DEcIDE Network and Healthcare-Associated Infections Program, and the CDC Prevention Epicenters Program.

Lancet Infect Dis. 2016 Jan;16(1):70-79. doi: 10.1016/S1473-3099(15)00238-8. Epub 2015 Nov 27.

Supplemental Content

Loading ...
Support Center